Dibenzo[C] chromen-6-one derivatives as anti-cancer agents

Details for Australian Patent Application No. 2002234466 (hide)

Owner Paloma Pharmaceuticals, Inc.

Inventors Zhu, Shuguang; Redden, Peter; Schmidt, jonathan Martin; Whelan, John; Lazarowych, Natalie; Mercure, Julie

Agent Cullen & Co

Pub. Number AU-B-2002234466

PCT Pub. Number WO2002/066467

Priority 60/270,198 22.02.01 US; 09/934,086 21.08.01 US

Filing date 21 February 2002

Wipo publication date 4 September 2002

Acceptance publication date 16 February 2006

International Classifications

C07D 407/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

C07D 311/80 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-B-2002234466

13 October 2005 Assignment Registered

  NanoDesign Inc. The patent has been assigned to Paloma Pharmaceuticals, Inc.

16 February 2006 Application Accepted

  Published as AU-B-2002234466

15 June 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002234467-DRUG ELUTING DEVICE FOR TREATING VASCULAR DISEASES

2002234465-1,2-DIPHENYL-1-NAPHTHYL ETHENE DERIVATIVES, ANALOGS AND USE THEREOF